Infliximab-induced hepatitis in a patient with Crohn's disease [2];Hepatitis inducida por infliximab en un paciente con enfermedad de Crohn

Gastroenterologia y Hepatologia

Volumn 29, Issue 5, 2006, Pages 321-322

  Soto Fernandez S ^a   Gonzalez Carro P ^a   De Pedro Esteban, A ^a   Legaz Huidobro, M L ^a   Perez Roldan F ^a   Roncero Garcia Escribano O ^a   Valbuena Gonzalez M ^a   Ruiz Carrillo, F ^a  

^a HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

CROHN DISEASE; HEPATITIS; HUMAN; LETTER; LIVER TOXICITY; MEDICAL LITERATURE; MEDICAL RESEARCH;

EID: 33745016470     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13087475     Document Type: Letter

References (10)

1. Hanauer SB. Review article: safety of infliximab in clinical trials. Aliment Pharmacol Ther. 1999; 13 Suppl 4:16-22.
2. Sandborn WJ, Hanauer SB. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol. 2002;97:2962-72.
3. Nahar IK, Shojania K, Marras CD, Alamgir AH, Anis AH. Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother. 2003;37:1256-65.
4. Germano V, Picchianti Diamanti A, Baccano G, et al Autoinmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis. 2005;64;1519-20.
5. Naranjo CA, Busto U, Seller EM, et al. A method for stimating the probability of adverse drug reaction. Clin Pharmacol Ther. 1981;30:239-45.
6. Menghini VV, Arora AS. Infliximab-associated reversible cholestatic liver disease. Mayo Clin Proc. 2001;76:84-6.
7. Saleem G, Li SC, MacPherson BR, Cooper SM. Hepatitis with interface inflammation infliximab therapy: comment on the article by Charles et al [letter to the editor]. Arthritis and Rheumatism. 2001;44:1966-8.
8. Michel M, Duvuox C, Hezode C, Cherqui D. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease. J Rheumatol. 2003;30:1524-5.
9. Esteve M, Saro C, González-Huix F, et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut. 2004;53:1363-5.
10. Magro F, Pereira P, Carneiro F, Veloso FT. Reactive hepatitis in a patient with Crohn's disease successfully treated with infliximab: does tumor necrosis factor alpha play a role in reactive hepatitis? Inflamm Bowel Dis. 2005;11:88-90.